Patent · US Expired

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

US7205409B2 · kind B2 · utility

80Cited by
4References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2004
Grant dateApr 17, 2007
Priority date
Expiry dateApr 2, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I),which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, syndrome X, hyperinsulinemia, β-cell failure, obesity, satiety disorders, atherosclerosis, and various immunomodulatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.